Tochigi, Japan

Yoshiaki Ichikawa


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Ichikai-machi, JP (2002)
  • Tochigi, JP (2005)

Company Filing History:


Years Active: 2002-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yoshiaki Ichikawa: Innovator in Antiallergic Agents

Introduction

Yoshiaki Ichikawa is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of antiallergic agents and atopic dermatitis treatments. With a total of 3 patents to his name, Ichikawa's work focuses on innovative solutions for allergy-related health issues.

Latest Patents

Ichikawa's latest patents include advancements in Interleukin-4 production inhibitors. These inventions relate to IL-4 production inhibitors, antiallergic agents, and atopic dermatitis preventives and improvers. Each of these inventions contains one or more compounds selected from hydroxyl-containing monoterpenes, hydroxyl-containing sesquiterpenes, and their acylated derivatives. Additionally, his inventions incorporate essential oils, such as cedarwood oil, and bath medicine compositions that include ingredients like cedrol, cedrenol, farnesol, patchouli alcohol, and vetiverol.

Career Highlights

Ichikawa is associated with Kao Corporation, a leading company in the field of consumer products and personal care. His work at Kao Corporation has allowed him to focus on developing innovative solutions that address common health concerns related to allergies and skin conditions.

Collaborations

Ichikawa has collaborated with notable coworkers, including Norikazu Iwase and Norihiro Tanaka. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yoshiaki Ichikawa's contributions to the field of antiallergic agents and atopic dermatitis treatments highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the industry and offers promising solutions for those affected by allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…